JMCR Partners

Integrate multi-technology target screening and drug discovery to improve innovation development efficiency.

Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics. We are exhaustive in our discovery and clinical efforts while nimble in our strategy and execution. We have assembled a world-class team of scientist entrepreneurs who are committed to accelerate innovative medicines in China and worldwide.

DIAGON manufactures and installs steel, aluminum, and wood structures. The company offers construction of ironwork, metal structures, sheet metal, and frameworks.

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins. It is committed to solving the problem of drug metabolism and the delivery of cytogenic drugs.

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases. VivaVision Biotech is dedicated to bringing new therapeutics to millions of patients suffering from chronic ocular or dermal inflammatory diseases.

Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics. We are exhaustive in our discovery and clinical efforts while nimble in our strategy and execution. We have assembled a world-class team of scientist entrepreneurs who are committed to accelerate innovative medicines in China and worldwide.

Riparian Pharmaceuticals is an early stage biotechnology company employing innovative models of vascular pathophysiology to discover novel therapeutics. The company develops medical therapies designed to treat cardiovascular and inflammatory diseases. The company is based in Boston Massachusetts.

Integrate multi-technology target screening and drug discovery to improve innovation development efficiency.

SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary CellSqueeze technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.

Tekeluo Biotech is a healthcare company.

Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics. We are exhaustive in our discovery and clinical efforts while nimble in our strategy and execution. We have assembled a world-class team of scientist entrepreneurs who are committed to accelerate innovative medicines in China and worldwide.

Viva Biotech offers global innovative drug R&D companies one-stop comprehensive services ranging from early structure-based drug R&D to commercial drug delivery. Using its advantages in the field of structure-based drug discovery (SBDD) technology, it provides global partners with CRO services in the new drug research stage and has established X-ray protein crystal technology, cryo-electron microscopy (Cryo-EM), and affinity mass spectrometry screening technology (ASMS), surface plasmon resonance (SPR), hydrogen-deuterium exchange mass spectrometry (HDX-MS), computer-aided drug design, and other advanced technology platforms.

Mirata Pharmaceuticals produces options for patients and physicians that provide the powerful pain relieving benefits of opioids. This is the next range of analgesic medications. The company's contact modes are phone and physical address.

Endurance Biotech is a biotechnology company based in Orange, California. The company was founded in 2015 by Fauad Hasan, Mike Jarpe, Susan Abushakra, and Wajdie Ahmad.

Endurance Biotech is a biotechnology company based in Orange, California. The company was founded in 2015 by Fauad Hasan, Mike Jarpe, Susan Abushakra, and Wajdie Ahmad.

The pharmaceutical industry has struggled to identify small molecule inhibitors of PCSK9 function. This has been explained by the expansive but flat binding interface between PCSK9 and the LDL receptor, spanning nearly 800 square angstroms. To date, only monoclonal antibodies have been able to target this region of PCSK9. We have discovered bona fide small molecule inhibitors of PCSK9 function that are orally bioavailable across multiple preclinical species. Guided by dozens of high-resolution x-ray structures of our molecules bound to PCSK9, we have utilized structure-based design to achieve picomolar affinity.

Flash is developing an oral compound to prevent AML relapse using novel findings linking HCK to AML. This small molecule will inhibit HCK and FLT3-ITD for the treatment of cancer. They have identified five potential compounds for further testing. One is moving on to IND filing while the other four are going to begin animal toxicology testing.

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases. VivaVision Biotech is dedicated to bringing new therapeutics to millions of patients suffering from chronic ocular or dermal inflammatory diseases.

Epigenetic-based Cancer Diagnostics and Prognostics

Since being founded in December 2014 Kickback built some of the largest esports gaming products for desktop games on the internet.

Tabomedex focuses on the R&D of new drugs related to type 2 diabetes. They mainly study the mechanism of action of MK2 and achieve the effect of controlling blood glucose level by inhibiting MK2, namely inhibiting the effect of downstream avtivating enzymes.

Stripe, Inc. is a global technology company that provides application programming interfaces (APIs) and tools designed to facilitate online payment processing for businesses. Its comprehensive platform includes solutions for payments, subscriptions, fraud detection, and data analytics, among others. Stripe's offerings, such as Stripe Connect for routing payments, Stripe Radar for fraud prevention, and Stripe Checkout for seamless transaction processes, cater to a diverse clientele ranging from startups to established enterprises. The company also addresses financing challenges faced by online businesses through Stripe Capital, which offers fast and flexible funding options. With operations in multiple countries, including the United States, the United Kingdom, and Singapore, Stripe aims to simplify financial infrastructure and support the growth of internet-based businesses, thereby contributing to the overall economic landscape of the digital economy. Founded in 2010 and headquartered in San Francisco, California, Stripe has established partnerships with leading technology firms to enhance its service capabilities.